CKD Flashcards

1
Q

3 Primary Kidney Functions

A
  1. Filtration of blood
  2. Regulation of fluid and electrolytes & acid base balance
  3. Excretion of metabolic waste products
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 Secondary Kidney Functions

A

To regulate:
1. BP (RAAS system)
2. Bone density
3. Erythropoiesis (RBC production)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the RAAS system stand for? What 3 factors regulate BP from the RAAS system?

A

Renin-angiotensin-aldosterone system

Regulates BP by increasing salt reabsorption, water reabsorption, and vascular tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does the RAAS system work?

A

Renin splits angiotensinogen into angiotensin I which is split by ACE (angiotensin-converting enzymes) in the lungs and kidney into angiotensin II which causes vasoconstriction and the release of aldosterone and ADH in the adrenal gland which causes salt retention (more water in body increases BV and BP) and K+ excretion in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CKD is defined by the presence of:

A

either kidney damage or GFR < 60 mL/min/1.73 m2 for 3 months or longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Description of stage 5 CKD

A

End-stage Renal Disease (ESRD)

Kidney failure, GFR <15 (or dialysis), action is renal replacement therapy (if uremia present and Pt desires treatment)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Normal GFR

A

125 mL/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Leading causes of ESRD

A

DM (38%), Renal vascular disease (50%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

2 ESRD tx options

A

Renal Replacement Therapy (either HD or PD)
Transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

2 General Clinical manifestation of CKD

A
  1. Retained Urea, creatinine, phenols, hormones, electrolytes, and water
  2. Uremia (when GFR<10, syndrome that incorporates all S&S seen in various systems throughout body due to waste product retention and excess fluid)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Psychological S&S of CKD

A

anxiety, depression (changes in body image with devices)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

CV S&S of CKD!!

A

HTN (fluid retention)
HF
L ventricular hypertrophy (has to work harder)
Peripheral edema
Dysrhythmias
Uremic pericarditis
CAD
Peripheral artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GI S&S of CKD

A

Anorexia
NV (increased urea circulating)
GI bleeding
Gastritis
Inflammation of GI mucosa (increased urea circulating)
Uremic fetor (urine breath odor)
Constipation (limited fluid intake)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Endocrine/Reproductive S&S of CKD

A

Hyperparathyroidism
Thyroid abnormalities
Amenorrhea
Erectile dysfunction
Infertility
Decreased libido
Low sperm counts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Metabolic S&S of CKD

A

Carbohydrate intolerance: Insulin resistance d/t insulin antagonists (ex. urea, a waste product) circulating = hyperglycemia and a need for less insulin because it’s already circulating but the waste prevents it from acting. Insulin is dependent on kidneys for excretion.

Hyperlipidemia: hyperinsulinemia stimulates triglyceride production in liver

Waste product accumulation - Kidney can’t filter out wastes, GFR ↓ and BUN ↑ and serum creatinine levels ↑

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hematological S&S of CKD

A

Anemia: decreased erythropoietin production (what stimulates RBC production in bone marrow), causes fatigue and SOB (increased O2 demand). Angina is secondary to anemia in a predisposed Pt (like a smoker).

Bleeding: defect platelet function, usually corrected with PD or HD

Infection: changed leukocyte function, diminished inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Neurological S&S of CKD

A

fatigue, headache, sleep disturbances, encephalopathy, restless legs syndrome, muscle twitching, apathy, decreased ability to concentrate, peripheral neuropathy

Because of increased nitrogenous waste, electrolyte imbalance, metabolic acidosis, axonal atrophy, and demyelination of nerve fibers. Most change once on dialysis

18
Q

Ocular S&S of CKD

A

HTN retinopathy

19
Q

Respiratory S&S of CKD

A

Kussmaul’s resps
Dyspnea
Pulmonary edema (fluid overload)
Uremic pleuritis
Uremic pneumonitis
Pleural effusion
Predisposition to respiratory infection

20
Q

Integumentary S&S of CKD

A

Pruritus (most common - d/t increased serum urea)
Ecchymosis
Dry, scaly skin
Uremic frost

21
Q

Musculo-skeletal S&S of CKD

A

Osteomalacia (bone demineralization)
Osteitis fibrosa (↑ PTH)
CKD-MBD (CKD mineral and bone disorder)
Vascular and soft tissue calcification (↑ serum Ca, ↑ serum phosphate)

Decreased kidney function → less conversion of activated Vit D which is essential for Ca absorption in GI → Hypocalcemia → causes PTH excretion → stimulates bone demineralization → releases phosphate → hyperphosphatemia decreases Ca serum → causes PTH excretion → parathyroid gland hypertrophy

22
Q

Peripheral neuropathy S&S of CKD

A

paresthesia, restless legs syndrome

23
Q

GU S&S of CKD

A

Polyuria - in early stages due to inability of kidneys to concentrate urine. Often nocturia. 1.010 specific gravity.

Oliguria - in worsening stages. < 400-500 mL/day

Anuria - urine output < 40mL/day

24
Q

Electrolyte/Acid-Base imbalances

A

K: Hyperkalemia - most serious electrolyte disorder in kidney disease, can cause fatal dysrhythmias when K+ > 7-8 mmol/L in blood. Kidneys not able to excrete K+ into urine.

Na+ : Dilutional hyponatremia - retained longer with water causing edema, HTN, CHF

Ca and phosphate (PO₄³⁻) alterations

Mg alterations

Metabolic acidosis: HCO3 can’t be reabsorbed (plasma bicarb falls to 16-20 mmol/L), makes body less basic and more acidic, as well acidic ammonia can not be excreted

25
Q

When to treat K+ imbalance

A

When K+ > 3.5 mmol/L

26
Q

What can become deficient in HD?

A

Folic acid - related to RBC maturation, removed by dialysis so replaced supplementally

27
Q

Why morbidity and mortality from CVD high in Pts with CKD

A

Worsened by sodium retention, increased extracellular volume, vascular changes from long standing HTN and accelerated atherosclerosis from elevated triglyceride levels are responsible for many of the CV complications that end up ensuing pts with CKD

28
Q

Diagnostic studies for CKD

A

Urinalysis dipstick evaluation
Albumin-creatinine ratio (1st AM void)
Renal ultrasound
Xray KUB (kidneys, ureters, bladder)
CT KUB
Renal biops

29
Q

What is the earliest marker of kidney damage

A

Proteinuria (albumin)

30
Q

What patients are at high risk of CKD that should be routinely screened for proteinuria?

A

DM
HTN
Vascular diseases
Autoimmune diseases
GFRs
Edema

31
Q

Normal urinalysis

A

clear, light yellow/amber
1.005-1.03 specific gravity (concentration of solutes)
pH - 4.6-8
No protein, RBC, glucose, ketones, nitrites, leukocyte esterase, casts, and bilirubin (product of RBC breakdown removed by liver into bile)

May see RBCs in pts menstruating, kidney stones, and UTI

32
Q

What is BUN

A

Measures urea levels in the blood, elevated if excretion is insufficient

33
Q

Creatinine

A

nitrogenous waste produce from muscle metabolism, elevated if excretion is insufficient

34
Q

Creatinine clearance

A
  • commonly used to assess GFR, determines how efficiently kidneys clear creatinine from blood
35
Q

GFR

A

how fast blood is filtered through the glomerulus

36
Q

CP7

A

Channel of 7 blood tests
1. Na
2. K+
3. Creatinine
4. BUN
5. eGFR
6. Glucose
7. Cl-

37
Q

Management of CKD

A

Correcting ECF volume overload
Nutrition
Erythropoietin therapy
Ca supplementation, phosphate binders, HTN meds, lowering K+
Adjusting drug dosages to degree of renal function

38
Q

Hyperkalemia drug therapy

A

C BIG K+ D(rop)

C - Ca gluconate - stabilize myocardium
B - B2-adrenergic agonists (shift K+ into cells)
I - IV insulin (shift K+ into cells)
G - ^ with IV Glucose to manage hypoglycemia
K - Kayexalate (commonly used in stage 4, laxative action to exchange K and Na in bowel)
D - diuretics or dialysis

39
Q

HTN drug therapy

A

Thiazide or loop diuretics, CCB,
Non-DM: ACE inhibitors, ARB (angiotensin II receptor blocker) agents

Target BP in CKD pts should be < 140/90 and 130/80 in DM pts

40
Q

CKD-MBD drug therapy

A

Phosphate restriction < 1000mg/day
Phosphate binders (Ca carbonate binds phosphate in bowel and excretes in stool, Sevelamer hydrochloride lowers cholesterol and LDLs)
Vit D supplements

If med intervention does not help bone breakdown, parathyroidectomy may occur

41
Q

Anemia therapy

A

Erythropoiesis-stimulating agents (ESA) IV or SC
Iron supplements
Folic acid supplements (needed for RBC formation)
Avoid blood transfusions

42
Q

Drug toxicity is commonly produced by:

A

digoxin, PO glycemic agents, antibiotics, opioids, NSAIDs